Biotechnology

Antengene to Present Preclinical Data Demonstrating the Synergistic Effect of the Combination of XPO1 and mTORC1/2 Inhibition for the Treatment of Triple-Hit DLBCL at AACR Annual Meeting 2021

SHANGHAI and GAITHERSBURG, Md., March 22, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematolog...

2021-03-22 08:00 2513

Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing

HANGZHOU, China, March 22, 2021 /PRNewswire/ -- Innoforce Pharmaceuticals ("INF"), a biopharmaceutical innovation and partnership company, announced today the completion of a625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020. The Series A ...

2021-03-22 08:00 3776

Qiming's Portfolio Company Connect Biopharma Lists on Nasdaq

SHANGHAI, March 20, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Connect Biopharma today listed on the Nasdaq with the stock code "CNTB". The issue price isUS$ 17.00/ADS. The stock opened at US$19.55/ADS and closed atUS$18.49/ADS on the first trading day, up 8.8%, with a market...

2021-03-20 09:00 15230

Samsung Biologics Unveils Strong Performance and Future Plans at its 10th Annual General Meeting of Shareholders

INCHEON, South Korea, March 18, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced a strong year in 2020 as it reported1 trillion won in target sales within just a decade at its 10th Annual General Meeting (AGM) on March 19th Korea time.

2021-03-19 09:49 4693

MGI Contributes to Africa's COVID-19 Response Efforts

SHENZHEN, China, March 18, 2021 /PRNewswire/ -- MGI , a global life-science technology innovator, lends a hand to resource-restrained African countries in response to the surge of local COVID-19 cases. New COVID-19 variants have emerged in Africa causing growing concerns...

2021-03-18 22:02 2287

BioVaxys Enters Agreement With Inotiv To Conduct Preclinical Toxicity Studies For Its Covid-T™ Immunodiagnostic Program

VANCOUVER, BC, March 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into an agreement with Bioanalytical Systems, Inc. d...

2021-03-18 20:09 4204

Microba Life Sciences appoints experienced executive Mark Capone to the Board

BRISBANE, Australia, March 18, 2021 /PRNewswire/ -- Microba Life Sciences  has appointed international executive, Mark Capone, as a Non-Executive Director of the Board, bringing with him more than 35 years of experience in the life sciences sector. Mr Capone spent 17 ...

2021-03-18 12:49 3847

Epredia And Paige Announce Global Commercial Distribution Agreement For Digital Pathology Software

PORTSMOUTH, N.H., March 17, 2021 /PRNewswire/ -- Epredia, a global leader in precision cancer diagnostics, and Paige, a global leader in AI-based diagnostic software in pathology, have announced today that they have entered into a commercial distribution agreement for Paige's comprehensive portfo...

2021-03-18 01:02 1438

Biobohemia Released Paper on the Discovery of the Antigenic Essence of Cancer Cells

BOSTON, March 17, 2021 /PRNewswire/ -- Scientists announced today that they have discovered why they have not succeeded in developing a vaccine against cancer. Vaccination is a powerful tool that has helped us cope with many dangerous diseases, and it is an effective means of combatting the curre...

2021-03-17 20:00 1401

111, Inc. Enters into First-Ever Strategic Partnership with BeiGene

SHANGHAI, March 17, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, announced today it has entered into a strategic cooperation agreem...

2021-03-17 18:50 4402

GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19

SINGAPORE, March 17, 2021 /PRNewswire/ -- GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have ...

2021-03-17 17:23 3820

Transcenta Continues to Push the Boundary of Cell Culture Productivity by Achieving > 6 g/L PER Day Volumetric Productivity in Continuous Perfusion Platform

SUZHOU and HANGZHOU, China, March 16, 2021 /PRNewswire/ -- Transcenta, a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced a major breakthrough in its continuous perfusion cell culture p...

2021-03-17 08:00 1497

GenScript receives "Best Contract Research Organization Award" in the 4th Annual Asia-Pacific Bioprocessing Excellence Awards Ceremony 2021

SINGAPORE, March 16, 2021 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) receives the "Best Contract Research Organization Award" on the 4th Annual Asia Pacific Bioprocessing Excellence Awards Ceremony 2021held on 16th March 2021. The award follows GenScri...

2021-03-16 20:57 3578

VolitionRx Limited Schedules Full Fiscal Year 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, March 16, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Tuesday, March 23, at 8:00 a.m. Eastern time to discuss its financial and operating results for the full fiscal year 2020, in addition to providing ...

2021-03-16 20:30 5258

QBiotics Welcomes TDM Growth Partners As Cornerstone Investor in a Capital Raise To Accelerate Drug Development Timelines

Key highlights: * QBiotics welcomes TDM Growth Partners as cornerstone investor * TDM Growth Partners is investing A$50 million into QBiotics to accelerate QBiotics' human drug development pipeline, support marketing of the company's veterinary pharmaceutical STELFONTA® and strengthen the QBi...

2021-03-16 06:35 2404

Microba Life Sciences partners with Unilever to target sleep through the gut microbiome

BRISBANE, Australia, March 15, 2021 /PRNewswire/ -- Experts in gut microbiome analysis, Microba Life Sciences , is empowering global consumer goods companyUnilever  to take a novel approach to this problem by exploring the links between sleep...

2021-03-15 21:59 2786

BioVaxys Enters Major Bioproduction Agreement With Wuxi Biologics (Hong Kong) Ltd. To Synthesize Proteins For Its SARS-CoV-2 Vaccine And COVID-T™ Immunodiagnostic Programs

VANCOUVER, British Columbia, March 15, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized protein vaccines for antiviral and cancer applications, announced today that it has entered into a major bioproduction agreement w...

2021-03-15 20:00 2735

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 3000

Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal

HONG KONG, March 15, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-bindin...

2021-03-15 19:00 4871

Antengene Included in the Shenzhen-Hong Kong Stock Connect

SHANGHAI and HONG KONG, March 14, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and o...

2021-03-15 09:40 2940
1 ... 213214215216217218219 ... 279